511165037	511165037	CD	B-NP	O
|	|	NNP	I-NP	O
JSH	JSH	NNP	I-NP	O
|	|	VBD	B-VP	O
93560858	93560858	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6456499	6456499	CD	B-NP	O
|	|	CC	I-NP	O
10/30/2007	10/30/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Atypical	Atypical	JJ	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/29/2007	9/29/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/3/2007	1/3/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
MCONNELL	MCONNELL	NNP	B-NP	O
,	,	,	O	O
KIP	KIP	NNP	B-NP	O
S	S	NNP	I-NP	O
673-19-11-7	673-19-11-7	CD	I-NP	O
Bradsho	Bradsho	NNP	I-NP	O
Rd.	Rd.	NNP	I-NP	O
,	,	,	O	O
E	E	NNP	B-NP	O
,	,	,	O	O
Iowa	Iowa	NNP	B-NP	O
78706	78706	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
3/20/07	3/20/07	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BARRIER	BARRIER	NNP	B-NP	O
,	,	,	O	O
ULYSSES	ULYSSES	NNP	B-NP	O
QUINTON	QUINTON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

AMLODIPINE	AMLODIPINE	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

ISOSORBIDE	ISOSORBIDE	NNP	B-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

METOPROLOL	METOPROLOL	NNP	B-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	B-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

FUROSEMIDE	FUROSEMIDE	RB	B-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

DOCUSATE	DOCUSATE	JJ	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

OMEPRAZOLE	OMEPRAZOLE	RB	B-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

ALTRAM	ALTRAM	NN	B-NP	O
25	25	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

SENNOSIDES	SENNOSIDES	NNS	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

SOLIFENACIN	SOLIFENACIN	NN	B-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
May	May	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/1/07	8/1/07	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
615583356	615583356	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
ROFECOXIB	ROFECOXIB	NN	B-NP	B-protein
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
constipated	constipate	VBN	I-VP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
takes	take	VBZ	B-VP	O
aspirin	aspirin	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-DNA
NORVASC	NORVASC	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
AMLODIPINE	AMLODIPINE	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
5	5	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

COLACE	COLACE	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LEXAPRO	LEXAPRO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESCITALOPRAM	ESCITALOPRAM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/1/07	8/1/07	CD	B-NP	O
by	by	IN	B-PP	O
TRONNES	TRONNES	NNP	B-NP	O
,	,	,	O	O
GERRY	GERRY	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ULTRAM	ULTRAM	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
327146517	327146517	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ESCITALOPRAM	ESCITALOPRAM	NNP	B-NP	O
OXALATE	OXALATE	NNP	I-NP	O
&	&	CC	I-NP	O
TRAMADOL	TRAMADOL	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
GLYBURIDE	GLYBURIDE	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
IMDUR	IMDUR	NNP	I-NP	O
ER	ER	NN	I-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
60	60	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
for	for	IN	B-PP	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Give	Give	NN	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
ATIVAN	ATIVAN	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
LORAZEPAM	LORAZEPAM	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
0.25	0.25	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Anxiety	Anxiety	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/20/07	3/20/07	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
TOPROL	TOPROL	NN	B-NP	O
XL	XL	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
959200630	959200630	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
ATENOLOL	ATENOLOL	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
FATIGUE	FATIGUE	NN	B-NP	O
WITH	WITH	NN	I-NP	O
ALL	ALL	NN	I-NP	O
B-BLOCKERS	B-BLOCKERS	NNS	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-protein
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	I-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
SL	SL	NN	I-NP	I-protein
q5min	q5min	NN	I-NP	I-protein
x	x	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
PRN	PRN	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
PRILOSEC	PRILOSEC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
SENNA	SENNA	NNP	I-NP	O
TABLETS	TABLETS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SENNOSIDES	SENNOSIDES	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1-2	1-2	NN	I-NP	B-DNA
TAB	TAB	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BID	BID	NNP	I-NP	I-DNA
PRN	PRN	NNP	I-NP	I-DNA
Constipation	Constipation	NNP	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	I-DNA
20	20	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BEDTIME	BEDTIME	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

ULTRAM	ULTRAM	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
TRAMADOL	TRAMADOL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/1/07	8/1/07	CD	B-NP	O
by	by	IN	B-PP	O
GNATEK	GNATEK	NNP	B-NP	O
,	,	,	O	O
ROLLAND	ROLLAND	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ULTRAM	ULTRAM	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
327146517	327146517	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
FENTANYL	FENTANYL	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
nausea	nausea	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-VP	O
OXYCODONE	OXYCODONE	VB	I-VP	O
CONTROLLED	CONTROLLED	VBN	B-NP	O
RELEASE	RELEASE	NN	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
vomiting	vomit	VBG	I-VP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
takes	take	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/1/07	8/1/07	CD	B-NP	O
by	by	IN	B-PP	O
ZWOLAK	ZWOLAK	NNP	B-NP	O
,	,	,	O	O
COLIN	COLIN	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ESCITALOPRAM	ESCITALOPRAM	NNP	B-NP	O
OXALATE	OXALATE	NNP	I-NP	O
&	&	CC	I-NP	O
TRAMADOL	TRAMADOL	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
VESICARE	VESICARE	NN	I-NP	O
5	5	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Marcelino	Marcelino	NNP	B-NP	O
Renicker	Renicker	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
please	please	NN	I-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Romberg	Romberg	NNP	I-NP	O
in	in	IN	B-PP	O
1-2wks	1-2wk	NNS	B-NP	O
-RRB-	-RRB-	NNP	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Yong	Yong	NNP	I-NP	O
Hardnette	Hardnette	NNP	I-NP	O
10/9/07	10/9/07	CD	I-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
scheduled	schedule	VBN	I-NP	O
,	,	,	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
ETHYL	ETHYL	NN	B-NP	O
ALCOHOL	ALCOHOL	NN	I-NP	O
,	,	,	O	O
PROCHLORPERAZINE	PROCHLORPERAZINE	NN	B-NP	O
,	,	,	O	O
LISINOPRIL	LISINOPRIL	NN	B-NP	O
,	,	,	O	O
ATENOLOL	ATENOLOL	NN	B-NP	O
,	,	,	O	O
PIMOZIDE	PIMOZIDE	NN	B-NP	O
,	,	,	O	O
FENTANYL	FENTANYL	NN	B-NP	O
,	,	,	O	O
zophran	zophran	NN	B-NP	O
,	,	,	O	O
ROFECOXIB	ROFECOXIB	NN	B-NP	B-protein
,	,	,	O	O
OXYCODONE	OXYCODONE	NN	B-NP	O
CONTROLLED	CONTROLLED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Atypical	Atypical	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Atypical	Atypical	NNP	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
Hx	Hx	NNP	I-NP	O
sick	sick	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
Rx	Rx	NN	I-NP	O
=	=	SYM	B-VP	O
DDD	DDD	NN	B-NP	O
pacer	pacer	NN	I-NP	O
Hx	Hx	NN	I-NP	O
Hodgkins	Hodgkin	VBZ	B-VP	O
Rx	Rx	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
ABVDx13	ABVDx13	NN	I-NP	O
Hx	Hx	NN	I-NP	O
of	of	IN	B-PP	O
BOOP	BOOP	NN	B-NP	B-protein
from	from	IN	B-PP	O
bleomycin	bleomycin	NN	B-NP	O
NIDDM	NIDDM	NN	I-NP	O
recurrent	recurrent	JJ	I-NP	O
rest	rest	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
known	know	VBN	I-NP	O
CAD	CAD	NN	I-NP	O
HTN	HTN	NN	I-NP	O
s/p	s/p	NN	I-NP	O
PTCA	PTCA	NN	I-NP	O
RCA	RCA	NN	I-NP	O
distant	distant	JJ	I-NP	O
tobac	tobac	NN	I-NP	O
hypercholosterolemia	hypercholosterolemia	NN	I-NP	O
imaging	image	VBG	B-VP	O
PVD	PVD	NN	B-NP	O
w/h/o	w/h/o	NN	I-NP	O
claudication	claudication	NN	I-NP	O
s/p	s/p	NN	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
h/o	h/o	NN	I-NP	O
spinal	spinal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
depression	depression	NN	I-NP	O
October	October	NNP	I-NP	O
,	,	,	O	O
RCA50	RCA50	NN	B-NP	B-protein
,	,	,	O	O
OM1-70	OM1-70	NN	B-NP	O
ETTs	ETT	NNS	I-NP	O
,	,	,	O	O
mult	mult	NN	B-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
-LRB-	-LRB-	SYM	I-NP	B-protein
-	-	HYPH	O	O
-RRB-	-RRB-	SYM	O	O
ECHO	ECHO	NN	B-NP	O
10/11	10/11	CD	I-NP	O
,	,	,	O	O
LVH	LVH	NN	B-NP	B-protein
,	,	,	O	O
LAE	LAE	NN	B-NP	B-protein
,	,	,	O	O
1MR	1MR	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Chest	Ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
*****	*****	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
86yo	86yo	CD	B-NP	O
F	F	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
CAD	CAD	NN	I-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
PCI	PCI	NN	I-NP	I-protein
,	,	,	O	O
AS	AS	NN	B-NP	O
s/p	s/p	NN	I-NP	O
AVR	AVR	NN	I-NP	O
'03	'03	CD	I-NP	O
,	,	,	O	O
SSS	SSS	NN	B-NP	O
s/p	s/p	NN	I-NP	O
PPM	PPM	NN	I-NP	O
'93	'93	CD	I-NP	O
and	and	CC	O	O
diastolic	diastolic	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
who	who	WP	B-NP	O
p/w	p/w	VBP	B-VP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
that	that	WDT	B-NP	O
came	come	VBD	B-VP	O
on	on	RP	B-PRT	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
and	and	CC	O	O
resolved	resolve	VBN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	I-NP	O
SLN	SLN	NN	I-NP	B-protein
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
pressure	pressure	NN	I-NP	O
began	begin	VBD	B-VP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
fear	fear	NN	B-NP	O
,	,	,	O	O
radiated	radiate	VBN	B-VP	O
to	to	TO	B-PP	O
R	R	NN	B-NP	O
shoulder	shoulder	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
w	w	NN	B-NP	O
/	/	SYM	O	O
diaphresis	diaphresis	NN	B-NP	O
and	and	CC	I-NP	O
sob	sob	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
n/v	n/v	NN	I-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
releived	releive	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
SLN	SLN	NN	I-NP	B-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
3-4	3-4	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
similar	similar	JJ	B-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
over	over	IN	B-PP	O
last	last	JJ	B-NP	O
2	2	CD	I-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
admitted	admit	VBD	B-VP	O
6/12	6/12	CD	B-NP	O
and	and	CC	O	O
r/o	r/o	NN	B-NP	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

Adenosine	Adenosine	NN	B-NP	O
MIBI	MIBI	NN	I-NP	O
6/19	6/19	CD	I-NP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
sm	sm	NN	B-NP	O
reversible	reversible	JJ	I-NP	O
perfusion	perfusion	NN	I-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
DIAG	DIAG	NN	B-NP	O
territory	territory	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
increased	increase	VBN	B-NP	O
sob	sob	NN	I-NP	O
x	x	SYM	B-NP	O
2-3	2-3	CD	B-NP	O
months	month	NNS	I-NP	O
worsened	worsen	VBN	B-VP	O
over	over	IN	B-PP	O
last	last	JJ	B-NP	O
week	week	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
wt	wt	NN	I-NP	O
gain	gain	NN	I-NP	O
or	or	CC	I-NP	O
PND	PND	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
ASA	ASA	NNP	B-NP	O
,	,	,	O	O
BB	BB	NNP	B-NP	O
and	and	CC	O	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
r/o	r/o	NN	B-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

***	***	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
PCI	PCI	NN	I-NP	O
to	to	TO	B-PP	O
RCA	RCA	NN	B-NP	B-protein
,	,	,	O	O
AVR	AVR	NN	B-NP	O
'03	'03	CD	I-NP	O
c/b	c/b	NN	I-NP	O
CVA	CVA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
w/o	w/o	VBP	B-VP	O
residual	residual	JJ	B-NP	O
defects	defect	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
SSS	SSS	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
PPM	PPM	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	I-protein
'93	'93	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
Hodgkins	Hodgkins	NNP	B-NP	O
lymphoma	lymphoma	NN	I-NP	O
s/p	s/p	NN	I-NP	O
radiotherapy	radiotherapy	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
'93	'93	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
Bladder	Bladder	NN	B-NP	O
Ca	Ca	NN	I-NP	O
s/p	s/p	NN	I-NP	O
transurethral	transurethral	JJ	I-NP	O
resection	resection	NN	I-NP	O
,	,	,	O	O
Depression	Depression	NN	B-NP	O
,	,	,	O	O
spinal	spinal	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
bowel	bowel	NN	B-NP	O
perforation	perforation	NN	I-NP	O
s/p	s/p	NN	I-NP	O
colectomy	colectomy	NN	I-NP	O
,	,	,	O	O
R	R	NN	B-NP	B-protein
pleural	pleural	JJ	I-NP	I-protein
lung	lung	NN	I-NP	I-protein
nodule	nodule	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
increasing	increase	VBG	B-VP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
PVD	PVD	NN	B-NP	O
.	.	.	O	O

***	***	SYM	O	O
Home	Home	NNP	B-NP	O
Medications	Medication	NNPS	I-NP	O
:	:	:	O	O
Norvasc	Norvasc	NN	B-NP	O
10mg	10mg	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
ASA	ASA	NNP	B-NP	O
81mg	81mg	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
colace	colace	NN	B-NP	O
100mg	100mg	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Lexapro	Lexapro	NNP	B-NP	O
10mg	10mg	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
lasix	lasix	NN	B-NP	O
20mg	20mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
imdur	imdur	VBP	B-VP	O
30mg	30mg	CD	B-NP	O
daily	daily	JJ	I-NP	O
,	,	,	I-NP	O
toprol	toprol	NN	I-NP	O
75mg	75mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
prilosec	prilosec	NN	B-NP	O
20mg	20mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
zocor	zocor	NN	B-NP	O
20mg	20mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
SLN	SLN	NN	B-NP	B-protein
,	,	,	O	O
altram	altram	NN	B-NP	O
25mg	25mg	NN	I-NP	O
q6h	q6h	NN	I-NP	O
prn	prn	NN	I-NP	O
,	,	,	O	O
senna	senna	NN	B-NP	O
1	1	CD	I-NP	O
tab	tab	NN	I-NP	O
daily	daily	JJ	I-NP	O
prn	prn	NN	I-NP	O
,	,	,	O	O
vesicare	vesicare	NN	B-NP	O
5mg	5mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

***	***	SYM	O	B-cell_type
All	All	DT	O	I-cell_type
:	:	:	O	O
EtOH	EtOH	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
facial	facial	JJ	I-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
Procholorperazine	Procholorperazine	NN	B-NP	O
-	-	HYPH	B-VP	O
altered	alter	VBN	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
Lisniopril	Lisniopril	NNP	B-NP	O
-	-	HYPH	I-NP	O
angioedema	angioedema	NN	I-NP	O
,	,	,	O	O
Atenolol	Atenolol	NN	B-NP	O
-	-	HYPH	I-NP	O
fatigue	fatigue	NN	I-NP	O
,	,	,	O	O
dimozide	dimozide	NN	B-NP	O
-	-	HYPH	B-VP	O
altered	alter	VBN	B-NP	O
MS	MS	NN	I-NP	O
***	***	SYM	B-NP	O
SH	SH	NN	I-NP	O
:	:	:	O	O
lives	life	NNS	B-NP	O
alone	alone	RB	B-ADVP	O
,	,	,	O	O
quit	quit	NN	B-NP	O
smoking	smoking	NN	I-NP	O
30	30	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
etOH	etOH	NN	I-NP	O
***	***	SYM	B-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
97.2	97.2	CD	B-NP	O
65156/64	65156/64	CD	I-NP	O
16	16	CD	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
NAD	NAD	NN	I-NP	O
PERRL	PERRL	NN	I-NP	O
,	,	,	O	O
EOMI	EOMI	NN	B-NP	B-protein
,	,	,	O	O
dry	dry	JJ	B-NP	O
MM	MM	NN	I-NP	O
,	,	,	O	O
B	B	NN	B-NP	B-protein
carotid	carotid	NN	I-NP	I-protein
bruits	bruit	NNS	I-NP	I-protein
RRR	RRR	NN	I-NP	I-protein
,	,	,	O	O
nl	nl	NN	B-NP	B-protein
s1/s2	s1/s2	NN	I-NP	I-protein
,	,	,	O	O
III/VI	III/VI	NN	B-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
RUSB	RUSB	NNP	B-NP	O
Decreased	Decreased	NNP	I-NP	O
BS	BS	NNP	I-NP	O
at	at	IN	B-PP	O
bases	base	NNS	B-NP	O
bilaterally	bilaterally	RB	B-ADJP	O
soft	soft	JJ	I-ADJP	O
,	,	,	O	O
nt/nd	nt/nd	NN	B-NP	O
,	,	,	O	O
stoma	stoma	NN	B-NP	B-protein
c/d/i	c/d/i	NN	I-NP	I-protein
no	no	DT	B-NP	I-protein
peripheral	peripheral	JJ	I-NP	I-protein
edema	edema	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
+	+	SYM	I-NP	O
dp	dp	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
,	,	,	O	O
wwp	wwp	VBP	B-VP	O
A+O	A+O	NNP	B-NP	O
x3	x3	NN	I-NP	O
,	,	,	O	O
non-focal	non-focal	JJ	B-NP	O
neuro	neuro	NN	I-NP	O
exam	exam	NN	I-NP	O
***	***	SYM	B-NP	O
Labs	Lab	NNPS	I-NP	O
:	:	:	O	O
wbc	wbc	NN	B-NP	O
8.33	8.33	CD	I-NP	O
,	,	,	O	O
hct	hct	NN	B-NP	B-protein
39.2	39.2	CD	I-NP	I-protein
,	,	,	O	O
plt	plt	NN	B-NP	B-protein
296	296	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.0	1.0	CD	I-NP	I-protein
,	,	,	O	O
bun	bun	NN	B-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
0.9	0.9	CD	I-NP	O
,	,	,	O	O
Cardiac	Cardiac	JJ	B-NP	B-protein
biomarkers	biomarker	NNS	I-NP	I-protein
negative	negative	JJ	B-NP	I-protein
x	x	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

***	***	SYM	B-NP	O
Results	Result	NNS	I-NP	O
:	:	:	O	O
Echo	Echo	NN	B-NP	O
7/12	7/12	CD	I-NP	O
borderline	borderline	JJ	I-NP	O
concentric	concentric	JJ	I-NP	O
LVH	LVH	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
60-65	60-65	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
RWMAm	RWMAm	NNP	I-NP	O
,	,	,	O	O
paradoxical	paradoxical	JJ	B-NP	O
septal	septal	JJ	I-NP	O
motion	motion	NN	I-NP	O
,	,	,	O	O
abn	abn	VBP	B-VP	O
diastolic	diastolic	JJ	B-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	B-protein
AR	AR	NNS	I-NP	I-protein
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
gradient	gradient	NN	I-NP	O
of	of	IN	B-PP	O
19	19	CD	B-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
mild	mild	JJ	B-NP	O
TR	TR	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
effusions	effusion	NNS	I-NP	O
Cath	Cath	NN	I-NP	B-protein
5/10	5/10	CD	I-NP	I-protein
no	no	DT	B-NP	O
LM	LM	NN	I-NP	O
,	,	,	O	O
mid	mid	IN	B-ADVP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
DIAG	DIAG	NN	B-NP	O
1	1	CD	I-NP	O
35	35	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
DIAG	DIAG	NN	B-NP	O
2	2	CD	I-NP	O
45	45	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
multipl	multipl	NN	B-NP	O
40-50	40-50	CD	I-NP	O
%	%	NN	I-NP	O
RCA	RCA	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
5/25	5/25	CD	I-NP	I-protein
R	R	NN	I-NP	I-protein
sided	sided	JJ	I-NP	O
PPM	PPM	NN	I-NP	O
,	,	,	O	O
small	small	JJ	B-NP	O
R	R	NN	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
CPP	CPP	NN	I-NP	O
.	.	.	O	O

MIBI	MIBI	NN	B-NP	O
11/25	11/25	CD	I-NP	O
sm	sm	NN	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
mild	mild	JJ	B-NP	O
reversible	reversible	JJ	I-NP	O
perfusion	perfusion	NN	I-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
Diag	Diag	NN	B-NP	O
territory	territory	NN	I-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	O
systolic	systolic	JJ	I-NP	O
fxn	fxn	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
CT	CT	NN	I-NP	O
2/15	2/15	CD	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
of	of	IN	B-PP	O
pulm	pulm	NN	B-NP	O
nodule	nodule	NN	I-NP	O
in	in	IN	B-PP	O
LLL	LLL	NN	B-NP	B-cell_line
,	,	,	O	O
enlargement	enlargement	NN	B-NP	O
of	of	IN	B-PP	O
R	R	NN	B-NP	O
para-tracheal	para-tracheal	JJ	I-NP	O
node	node	NN	I-NP	O
.	.	.	O	O

***	***	SYM	O	O
A/P	A/P	NN	B-NP	O
86	86	CD	I-NP	O
yo	yo	NN	I-NP	O
F	F	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
CAD	CAD	NN	I-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
PCI	PCI	NN	I-NP	I-protein
,	,	,	O	O
AS	AS	NN	B-NP	O
s/p	s/p	NN	I-NP	O
AVR	AVR	NN	I-NP	O
,	,	,	O	O
sss	sss	NN	B-NP	O
s/p	s/p	NN	I-NP	O
PPM	PPM	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
several	several	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
CP	CP	NN	B-NP	B-DNA
in	in	IN	B-PP	O
last	last	JJ	B-NP	O
2	2	CD	I-NP	O
months	month	NNS	I-NP	O
that	that	WDT	B-NP	O
come	come	VBP	B-VP	O
on	on	RP	B-PRT	O
with	with	IN	B-PP	O
fear	fear	NN	B-NP	O
and	and	CC	I-NP	O
anxiety	anxiety	NN	I-NP	O
and	and	CC	O	O
worsening	worsen	VBG	B-VP	O
DOE	DOE	NNP	B-NP	O
now	now	RB	B-ADVP	O
p/w	p/w	VBP	B-VP	O
another	another	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
.	.	.	O	O

Ddx	Ddx	NN	B-NP	O
anxiety	anxiety	NN	I-NP	O
,	,	,	O	O
ACS	ACS	NN	B-NP	B-protein
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
bioprosthetic	bioprosthetic	JJ	B-NP	O
vavle	vavle	NN	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
CVI	CVI	NN	I-NP	O
:	:	:	O	O
Known	Know	VBN	B-NP	O
CAD	CAD	NN	I-NP	B-protein
,	,	,	O	O
MIBI	MIBI	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
perfusion	perfusion	NN	I-NP	O
defect	defect	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
no	no	DT	B-NP	O
new	new	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
non-cardiac	non-cardiac	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
comes	come	VBZ	B-VP	O
on	on	RP	B-PRT	O
with	with	IN	B-PP	O
anxiety/fear	anxiety/fear	NN	B-NP	O
,	,	,	O	O
occurs	occur	VBZ	B-VP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
exertion	exertion	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
sets	set	NNS	I-NP	O
of	of	IN	B-PP	O
negative	negative	JJ	B-NP	B-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
remained	remain	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
free	free	JJ	I-NP	O
throught	throught	VBN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
occasional	occasional	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
anxiety	anxiety	NN	I-NP	O
attacks	attack	VBZ	B-VP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
that	that	WDT	B-NP	O
relieved	relieve	VBD	B-VP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
ativan	ativan	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
ASA	ASA	NNP	B-NP	O
,	,	,	I-NP	O
BB	BB	NNP	I-NP	O
,	,	,	I-NP	O
zocor	zocor	NN	I-NP	O
.	.	.	O	O

Lipids	Lipid	NNS	B-NP	O
-LRB-	-LRB-	SYM	O	O
chol	chol	NN	B-NP	O
119	119	CD	I-NP	O
,	,	,	O	O
Tri	Tri	NNP	B-NP	O
142	142	CD	I-NP	O
,	,	,	O	O
HDL	HDL	NN	B-NP	B-protein
135	135	CD	I-NP	I-protein
,	,	,	O	O
LDL	LDL	NN	B-NP	B-protein
56	56	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
increased	increase	VBD	B-VP	O
her	her	PRP$	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
imdur	imdur	NN	B-NP	O
for	for	IN	B-PP	O
better	good	JJR	B-NP	O
bp	bp	NN	I-NP	O
control	control	NN	I-NP	O
and	and	CC	O	O
symptomatic	symptomatic	JJ	B-NP	O
relief	relief	NN	I-NP	O
of	of	IN	B-PP	O
angina	angina	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
although	although	IN	B-SBAR	O
likley	likley	NN	B-NP	B-protein
not	not	RB	B-VP	I-protein
having	have	VBG	I-VP	I-protein
true	true	JJ	B-NP	I-protein
angina	angina	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Rubin	Rubin	NNP	I-NP	O
Farahkhan	Farahkhan	NNP	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
CVP	CVP	NN	I-NP	O
:	:	:	O	O
Known	Know	VBN	B-NP	O
diastolic	diastolic	JJ	I-NP	O
HF	HF	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
DOE	DOE	NN	I-NP	O
over	over	IN	B-PP	O
last	last	JJ	B-NP	O
several	several	JJ	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

Recently	Recently	RB	B-ADVP	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
requiring	require	VBG	B-VP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

Durnig	Durnig	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
appeared	appear	VBD	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
lasix	lasix	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
some	some	DT	B-NP	O
hypertension	hypertension	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
sbp	sbp	NN	I-NP	O
in	in	IN	B-PP	O
150s	150	NNS	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
split	split	VBD	B-VP	O
her	her	PRP$	B-NP	O
norvasc	norvasc	NN	I-NP	O
into	into	IN	B-PP	O
bid	bid	NN	B-NP	O
dosing	dosing	NN	I-NP	O
for	for	IN	B-PP	O
tighter	tight	JJR	B-NP	O
control	control	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
imdur	imdur	NN	I-NP	O
.	.	.	O	O

May	May	MD	B-VP	O
need	need	VBP	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
anti-hypertensive	anti-hypertensive	JJ	B-NP	O
up-titrated	up-titrate	VBN	B-VP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
angioedema	angioedema	NN	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echo	echo	JJ	I-NP	O
cardiogram	cardiogram	NN	I-NP	O
pending	pende	VBG	B-VP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
as	as	IN	B-PP	O
OP	OP	NNP	B-NP	O
.	.	.	O	O

*	*	SYM	B-NP	B-protein
CVR	CVR	NN	I-NP	I-protein
:	:	:	O	O
no	no	DT	B-NP	O
issues	issue	NNS	I-NP	O
*	*	SYM	B-NP	O
Pulm	Pulm	NN	I-NP	O
:	:	:	O	O
***	***	SYM	B-NP	O
HIGH	HIGH	NN	I-NP	O
SUSPICION	SUSPICION	NN	I-NP	O
FOR	FOR	NN	I-NP	O
LUNG	LUNG	NN	I-NP	O
CA	CA	NN	I-NP	O
***	***	SYM	B-VP	O
given	give	VBN	B-PP	O
smoking	smoking	NN	B-NP	O
hx	hx	NN	I-NP	O
and	and	CC	O	O
recent	recent	JJ	B-NP	O
enlarging	enlarge	VBG	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
nodule	nodule	NN	I-NP	O
in	in	IN	B-PP	O
RLL	RLL	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
sm	sm	NN	I-NP	B-protein
R	R	NN	I-NP	I-protein
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

Needs	Need	NNS	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
further	further	JJ	I-NP	O
outpatient	outpatient	NN	I-NP	O
workup	workup	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
BOOP	BOOP	NN	B-NP	O
2/2	2/2	CD	I-NP	O
bleomycin	bleomycin	NN	I-NP	O
and	and	CC	O	O
diastolic	diastolic	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
DOE	DOE	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
GI	GI	NN	B-NP	O
:	:	SYM	O	O
h/o	h/o	NN	B-NP	O
bowel	bowel	NN	I-NP	O
perforation	perforation	NN	I-NP	O
s/p	s/p	NN	I-NP	O
colectomy	colectomy	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
colostomy	colostomy	NN	I-NP	O
.	.	.	O	O

Stoma	Stoma	NN	B-NP	O
appeared	appear	VBD	B-VP	O
C/D/I	C/D/I	NN	B-NP	B-protein
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
homebowel	homebowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
*	*	SYM	B-NP	O
GU	GU	NN	I-NP	O
:	:	:	O	O
Overactive	Overactive	JJ	B-NP	O
bladder	bladder	NN	I-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
GU	GU	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Recently	Recently	RB	B-NP	O
started	start	VBN	I-NP	O
vesicare	vesicare	NN	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
effect	effect	NN	I-NP	O
*	*	SYM	O	O
Endo	Endo	NNP	B-NP	O
:	:	:	O	O
DM	DM	NN	B-NP	O
on	on	IN	B-PP	O
glyburide	glyburide	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Kept	Kept	NN	B-NP	O
on	on	IN	B-PP	O
SSI	SSI	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
HGA1C	HGA1C	NN	I-NP	B-protein
was	be	VBD	B-VP	O
***	***	SYM	O	O
*	*	SYM	O	O
PPI	PPI	NN	B-NP	O
:	:	:	O	O
lovenox	lovenox	NN	B-NP	O
,	,	,	O	O
ppi	ppi	NN	B-NP	O
FULL	FULL	NN	I-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
To	To	TO	B-PP	O
Patient	Patient	NN	B-NP	O
:	:	:	O	O
You	You	PRP	B-NP	O
were	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
attack	attack	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
cause	cause	NN	I-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
our	our	PRP$	B-NP	O
evaluation	evaluation	NN	I-NP	O
we	we	PRP	B-NP	O
feel	feel	VBP	B-VP	O
that	that	IN	B-SBAR	O
your	your	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
atypical	atypical	JJ	B-ADJP	O
and	and	CC	O	O
most	most	RBS	B-ADJP	O
likely	likely	RB	I-ADJP	O
not	not	RB	B-ADJP	O
related	related	JJ	I-ADJP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
made	make	VBN	I-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
changes	change	NNS	I-NP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
increased	increase	VBD	B-VP	O
your	your	PRP$	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
imdur	imdur	NN	B-NP	O
from	from	IN	B-PP	O
30mg	30mg	CD	B-NP	O
to	to	TO	B-PP	O
60mg	60mg	CD	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
changed	change	VBD	B-VP	O
your	your	PRP$	B-NP	O
norvasc	norvasc	NN	I-NP	O
from	from	IN	B-PP	O
10mg	10mg	CD	B-NP	O
daily	daily	JJ	I-NP	O
to	to	TO	B-VP	O
5mg	5mg	VB	I-VP	O
twice	twice	RB	B-ADVP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
added	add	VBD	B-VP	O
ativan	ativan	NN	B-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
and	and	CC	I-NP	O
agitation	agitation	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
develope	develope	VBP	B-VP	O
recurrent	recurrent	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
concerning	concern	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
please	please	VB	B-VP	O
contact	contact	NN	B-NP	O
a	a	DT	B-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
may	may	MD	B-VP	O
try	try	VB	I-VP	O
taking	take	VBG	I-VP	O
ativan	ativan	RP	B-PRT	O
when	when	WRB	B-ADVP	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
especially	especially	RB	B-ADVP	O
if	if	IN	B-SBAR	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
brought	bring	VBN	I-VP	O
on	on	RP	B-PRT	O
by	by	IN	B-PP	O
fear	fear	NN	B-NP	O
or	or	CC	I-NP	O
anxiety	anxiety	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
1-2	1-2	CD	I-NP	O
weeks	week	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
sure	sure	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
tolerating	tolerate	VBG	I-VP	O
the	the	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
medications	medication	NNS	B-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
***	***	SYM	B-NP	O
ENLARGING	ENLARGING	NN	I-NP	O
PULM	PULM	NN	I-NP	O
NODULE	NODULE	NN	I-NP	O
W	W	NN	I-NP	O
/	/	SYM	B-NP	O
PLUERAL	PLUERAL	NN	I-NP	O
EFFUSION	EFFUSION	NN	I-NP	O
***	***	SYM	B-NP	O
High	High	JJ	I-NP	O
suspicion	suspicion	NN	I-NP	O
for	for	IN	B-PP	O
Ca	Ca	NN	B-NP	O
and	and	CC	O	O
needs	need	VBZ	B-VP	O
further	further	JJ	B-NP	O
OP	OP	NN	I-NP	O
work-up	work-up	NN	I-NP	O
*	*	SYM	B-NP	O
Up-titrate	Up-titrate	JJ	I-NP	O
bp	bp	NN	I-NP	O
medications	medication	NNS	I-NP	O
for	for	IN	B-PP	O
better	good	JJR	B-NP	O
control	control	NN	I-NP	O
*	*	SYM	B-NP	O
Have	Have	NN	I-NP	O
patient	patient	NN	I-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Appelgren	Appelgren	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
cardiology	cardiology	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
ZAIS	ZAIS	NNP	B-NP	O
,	,	,	O	O
ANTON	ANTON	NNP	B-NP	O
E	E	NNP	I-NP	O
MD	MD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FF47	FF47	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3/20/07	3/20/07	CD	I-NP	O
@	@	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
28	28	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

